Arizona School District Reaches Settlement with Altria for $3.2 Million.

Aug.24.2023
Arizona School District Reaches Settlement with Altria for $3.2 Million.
Tucson Unified School District (TUSD) reaches $3.2 million settlement with Altria as part of a collective lawsuit.

On August 24, the Tucson Unified School District (TUSD) in Arizona announced a settlement with Altria, in which they will receive a settlement amount of $3.2 million. Previously, the district had reached a settlement of around $10 million with Juul, both being part of the same class action lawsuit.

 

Dr. Ravi Shah, President of TUSD, stated:

 

Our staff has devoted a substantial amount of time conducting research, gathering evidence, and analyzing various aspects, all of which demonstrate the impact of Juul and Altria, as well as their influence on our school district.

 

The school district will begin receiving this sum of money starting at the end of this year and will continue to receive the remaining settlement funds in the coming years. The district's attorneys will receive 25% of the compensation amount. After deducting this fee, the school district will be left with approximately $10.3 million from these two settlements.

 

Ravi hopes that every cent of this money will be used to aid in the prevention and treatment of addiction issues among our students, as well as to meet their mental health needs. He stated that the school district already has plans in place to assist students, but the additional funding will further support their efforts.

 

Previously, Altria Group announced that it will pay $235 million to settle at least 6,000 lawsuits.

 

This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.

Rethinking Nicotine Harm Reduction: A Neuroscientist’s Perspective on Scientific Gaps and Future Directions — By Dr. Xin-an Liu
Rethinking Nicotine Harm Reduction: A Neuroscientist’s Perspective on Scientific Gaps and Future Directions — By Dr. Xin-an Liu
After France’s ANSES report on nicotine products and harm reduction, Dr. Xin-an Liu wrote to 2Firsts reassessing the field’s foundations. She argues the debate reveals gaps in evidence on long-term behavioral substitution, addiction pathways and neurobiological impacts, and calls for longitudinal research, integrated behavioral science and neuroimaging, clearer risk assessment and stronger transparency to ensure policy and next-generation product development rest on solid evidence.
Industry Insight
Feb.24
FDA Says Flavored ENDS Must Show “Added Benefit” as Small Manufacturers Seek Clearer Switching Benchmarks
FDA Says Flavored ENDS Must Show “Added Benefit” as Small Manufacturers Seek Clearer Switching Benchmarks
During the FDA PMTA roundtable session on “Studies of Adult Benefit,” officials said flavored ENDS must demonstrate “added benefit” over tobacco-flavored products under the APPH standard, including sustained complete switching evidence. Small manufacturers questioned switching benchmarks, study duration, and bridging expectations.
Feb.11
Singapore detected 59 large-scale vape smuggling cases in 2025, seizing about 230,000 items
Singapore detected 59 large-scale vape smuggling cases in 2025, seizing about 230,000 items
Singapore’s Ministry of Health said on Feb. 3 that authorities detected 59 large-scale vape smuggling cases in 2025 and seized about 230,000 vapes and accessories. Over the past two years, more than 10,000 online vape sale advertisements were removed, with about 99% linked to overseas platform posts. Enforcement includes bot-driven surveillance, public tip-offs, and site-blocking with partner agencies.
Feb.04 by 2FIRSTS.ai
FDA schedules online roundtable to gather small manufacturers’ input on ENDS PMTA requirements
FDA schedules online roundtable to gather small manufacturers’ input on ENDS PMTA requirements
FDA announced it will convene a Feb. 10, 2026 roundtable with small tobacco product manufacturers to gather feedback on PMTA submissions for ENDS products. The discussion will be viewable online, and a public docket is open for comments through March 12, 2026.
Feb.10 by 2FIRSTS.ai
Fontem Sues FDA Over Refusal-to-File Decision for Nicotine Pouch PMTAs
Fontem Sues FDA Over Refusal-to-File Decision for Nicotine Pouch PMTAs
According to a complaint filed on March 17 in the U.S. District Court for the Northern District of Texas, Fontem US, LLC and Texas retailer OM Investment, LLC sued the Food and Drug Administration and the Department of Health and Human Services over FDA’s refusal-to-file decision for certain Zone nicotine pouch PMTAs.
Mar.19 by 2FIRSTS.ai
China Tobacco Jiangsu Industrial Patent Points to 3D-Printed Nicotine Oral Products
China Tobacco Jiangsu Industrial Patent Points to 3D-Printed Nicotine Oral Products
Jiangsu China Tobacco Industrial Co., Ltd. has disclosed a patent describing a nicotine oral formulation produced using 3D printing technology. The invention enables a three-stage nicotine release system—rapid onset, sustained delivery and long-term release—through a layered structure with varying porosity. The technology reflects growing experimentation within China Tobacco’s research system around precision nicotine delivery for modern oral products.
Mar.09